Dark Forest Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-558
Closed -$38K 1715
2022
Q3
$38K Buy
+558
New +$30.8K 0.01% 551
2022
Q1
Sell
-168
Closed -$5K 1974
2021
Q4
$5K Buy
+168
New +$5.2K ﹤0.01% 1206

Other funds holding GBT

Dark Forest Capital Management's GBT Position: Q4 2022 in Review

Dark Forest Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 558 shares — an estimated $38K sold.

Dark Forest Capital Management first reported a position in GBT in Q4 2021 and held it in 2 quarters. The position peaked at $38K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Dark Forest Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 558 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $38K.
  • Dark Forest Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 2 quarters.
  • Dark Forest Capital Management's Global Blood Therapeutics, Inc. position peaked at $38K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Dark Forest Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.